Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Moodys
Harvard Business School
Baxter
McKesson

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Maribavir

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Maribavir?

Maribavir is an investigational drug.

There have been 9 clinical trials for Maribavir. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2007.

The most common disease conditions in clinical trials are Cytomegalovirus Infections, Infection, and Communicable Diseases. The leading clinical trial sponsors are Shire, Glaxo Wellcome, and [disabled in preview].

Recent Clinical Trials for Maribavir
TitleSponsorPhase
A Study Comparing the Pharmacokinetics and Palatability of Two Candidate Pediatric Powder-for-Oral-Suspension Formulations of Maribavir to the Current Maribavir Tablet Formulation Administered in Healthy Adult ParticipantsShirePhase 1
Study for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant RecipientsShirePhase 3
Efficacy and Safety of Maribavir in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to TreatmentShirePhase 3

See all Maribavir clinical trials

Clinical Trial Summary for Maribavir

Top disease conditions for Maribavir
Top clinical trial sponsors for Maribavir

See all Maribavir clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Dow
Moodys
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.